Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™): interim guidance, first issued 10 February 2021, updated 21 April 2021, last updated 30 July 2021

World Health Organization2021-07-302021-07-302021-07-30WHO/2019-nCoV/vaccines/SAGE_recommendation/AZD1222/2021.3https://iris.who.int/handle/10665/34338812 p.The Portuguese version is published by PAHO: https://iris.paho.org/handle/10665.2/54590enCC BY-NC-SA 3.0 IGOhttps://creativecommons.org/licenses/by-nc-sa/3.0/igoCOVID-19COVID-19 VaccinesBetacoronavirusDisease OutbreaksVaccinesGuidelineInterim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™): interim guidance, first issued 10 February 2021, updated 21 April 2021, last updated 30 July 2021Technical DocumentsWorld Health Organization